2014-09-29
2014-09-25
The Future of Aging and Aging Disease Prevention
http://www.prweb.com/releases/2014/09/prweb12195460.htm
Three distinguished experts have joined InSilico Medicine, including Donald Small, MD, PhD, Kristen Fortney, PhD and Alexey Moskalev, DSc.
InSilico Medicine proudly announces that Donald Small, MD, PhD, Kristen Fortney, PhD and Alexey Moskalev, DSc will aid the company’s mission to successful drug discovery and personalized medicine. It is clear meaningful progress is being made to battle aging from InSilico Medicine, considering the past major SAB additions.
About InSilico Medicine
InSilico Medicine was founded in early 2014 and has since developed
the OncoFinder and Geroscope. It is a company dedicated to finding novel
solutions towards aging and age-related diseases using advances in
genomics and big data analysis. Through internal expertise and extensive
collaborations with brilliant scientists, institutions, and highly
credible pharmaceutical companies, InSilico Medicine seeks to
revolutionize personalized science and drug discovery. More can be read
about InSilico Medicine, Inc. at http://www.insilicomedicine.com.
Subscribe to:
Posts (Atom)